Nancy A. Grygiel - May 5, 2024 Form 4 Insider Report for AMGEN INC (AMGN)

Role
SVP & CCO
Signature
/s/ Nancy A. Grygiel
Stock symbol
AMGN
Transactions as of
May 5, 2024
Transactions value $
-$25,526
Form type
4
Date filed
5/7/2024, 08:35 PM
Previous filing
May 3, 2024
Next filing
May 9, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMGN Common Stock Tax liability -$25.5K -82 -0.83% $311.29 9.8K May 5, 2024 Direct F1, F2
holding AMGN Common Stock 100 May 5, 2024 401(k) Plan F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,780 RSUs which will vest on 7/31/2024; 199 RSUs which will vest on 4/30/2025; 435 RSUs which will vest in installments of 214 on 5/2/2025, and one installment of 221 on 5/2/2026; and 635 RSUs which will vest in installments of 209 on 5/2/2025, 210 on 5/2/2026 and 216 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F2 These shares include 424 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
F3 These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.